JP2020526530A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020526530A5 JP2020526530A5 JP2020500810A JP2020500810A JP2020526530A5 JP 2020526530 A5 JP2020526530 A5 JP 2020526530A5 JP 2020500810 A JP2020500810 A JP 2020500810A JP 2020500810 A JP2020500810 A JP 2020500810A JP 2020526530 A5 JP2020526530 A5 JP 2020526530A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- seq
- lipid
- peptide antigens
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762530498P | 2017-07-10 | 2017-07-10 | |
| US62/530,498 | 2017-07-10 | ||
| PCT/CA2017/051336 WO2019010560A1 (en) | 2017-07-10 | 2017-11-09 | PHARMACEUTICAL COMPOSITIONS, METHODS OF PREPARATION USING LIPID VESICLE PARTICLES OF A DEFINED SIZE, AND USES THEREOF |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020526530A JP2020526530A (ja) | 2020-08-31 |
| JP2020526530A5 true JP2020526530A5 (enExample) | 2020-12-10 |
| JP7409594B2 JP7409594B2 (ja) | 2024-01-09 |
Family
ID=65000992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020500810A Active JP7409594B2 (ja) | 2017-07-10 | 2017-11-09 | 医薬組成物、規定のサイズの脂質ベシクル粒子を使用する調製物のための方法、及びそれらの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20200230057A1 (enExample) |
| EP (1) | EP3651733A4 (enExample) |
| JP (1) | JP7409594B2 (enExample) |
| CN (1) | CN111093623A (enExample) |
| AU (1) | AU2017423053A1 (enExample) |
| CA (1) | CA3069019A1 (enExample) |
| WO (1) | WO2019010560A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112188887A (zh) * | 2018-03-20 | 2021-01-05 | 免疫疫苗技术公司 | 用于将活性剂和免疫调节剂靶向递送至淋巴结的方法和组合物 |
| US11666644B2 (en) | 2018-09-04 | 2023-06-06 | Treos Bio Limited | Peptide vaccines |
| EP3923981A4 (en) * | 2019-02-15 | 2022-11-30 | Cleveland Clinic Foundation | Vaccine adjuvants and formulations |
| WO2020204173A1 (ja) * | 2019-04-05 | 2020-10-08 | 大日本住友製薬株式会社 | 水溶性アジュバントおよびそれを含有する組成物 |
| WO2020243115A1 (en) * | 2019-05-25 | 2020-12-03 | Infectious Disease Research Institute | Composition and method for spray drying an adjuvant vaccine emulsion |
| US20230348935A1 (en) * | 2020-09-24 | 2023-11-02 | Nant Holdings Ip, Llc | Vaccine compositions for mucosal immune response |
| WO2022064274A1 (en) * | 2020-09-28 | 2022-03-31 | Immunovaccine Technologies Inc. | Lipid compositions comprising polynucleotide antigens |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2906110A (en) * | 1959-09-29 | Silencing attachment for seamless | ||
| AU2005204385A1 (en) | 2004-01-07 | 2005-07-28 | Biomedical Research Models, Inc. | Methods for tailoring the immune response to an antigen or immunogen |
| JP5715051B2 (ja) | 2008-06-05 | 2015-05-07 | イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． | リポソーム、抗原、ポリヌクレオチド及び疎水性物質の連続相を含む担体を含む組成物 |
| JP5429710B2 (ja) | 2009-03-30 | 2014-02-26 | 独立行政法人放射線医学総合研究所 | 治療薬剤の標的部位への集積及び放出を追跡可能な治療薬剤含有リポソームおよびその製造方法 |
| KR101102834B1 (ko) * | 2010-02-24 | 2012-01-05 | 충남대학교산학협력단 | 신규한 리포좀 제조 방법 및 장치 |
| CU20100144A7 (es) | 2010-07-06 | 2012-06-21 | Centro Inmunologia Molecular | Composiciones vacunales a base de sticholisina encapsulada en liposomas |
| US20140199233A1 (en) | 2011-05-11 | 2014-07-17 | The Regents Of The University Of California | Enhanced Growth Inhibition of Osteosarcoma by Cytotoxic Polymerized Liposomal Nanoparticles Targeting the Alcam Cell Surface Receptor |
| CN103998058B (zh) * | 2011-10-06 | 2021-11-05 | 免疫疫苗技术有限公司 | 包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用 |
| CA2852777C (en) * | 2011-10-21 | 2020-10-27 | Celator Pharmaceuticals Inc. | Lyophilized liposomes |
| DK2773326T3 (en) * | 2011-11-04 | 2019-04-15 | Nitto Denko Corp | PROCEDURE FOR STERILE PREPARATION OF LIPID NUCLEIC ACID PARTICLES |
| HUE062466T2 (hu) | 2012-07-05 | 2023-11-28 | Taiwan Liposome Co Ltd | Eljárások arthritis kezelésére |
| US9693958B2 (en) | 2013-03-15 | 2017-07-04 | Cureport, Inc. | Methods and devices for preparation of lipid nanoparticles |
| CN106466299B (zh) * | 2015-08-19 | 2021-09-28 | 上海本素医药科技有限公司 | 以人参皂苷为膜材的空白脂质体、其制备方法及应用 |
| US11160861B2 (en) | 2015-11-18 | 2021-11-02 | Immunovaccine Technologies Inc. | Adjuvanting systems and water-free vaccine compositions comprising a polyI:C polynucleotide adjuvant and a lipid-based adjuvant |
| CN108289846B (zh) | 2015-12-08 | 2020-12-04 | 正大天晴药业集团股份有限公司 | 脂质体的制备方法 |
-
2017
- 2017-11-09 CA CA3069019A patent/CA3069019A1/en active Pending
- 2017-11-09 US US16/629,780 patent/US20200230057A1/en not_active Abandoned
- 2017-11-09 CN CN201780094129.5A patent/CN111093623A/zh active Pending
- 2017-11-09 AU AU2017423053A patent/AU2017423053A1/en not_active Abandoned
- 2017-11-09 EP EP17917340.6A patent/EP3651733A4/en not_active Withdrawn
- 2017-11-09 WO PCT/CA2017/051336 patent/WO2019010560A1/en not_active Ceased
- 2017-11-09 JP JP2020500810A patent/JP7409594B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020526530A5 (enExample) | ||
| JP7604519B2 (ja) | Ｒｎａコンストラクトおよびその使用 | |
| Chattopadhyay et al. | Nanoparticle vaccines adopting virus-like features for enhanced immune potentiation | |
| US8926994B2 (en) | Mesoporous silicon particles for the presentation of tumor antigens and adjuvant for anti-cancer immunity | |
| US11060096B2 (en) | RNA-based compositions and adjuvants for prophylactic and therapeutic treatment | |
| Li et al. | Rational design of polymeric hybrid micelles to overcome lymphatic and intracellular delivery barriers in cancer immunotherapy | |
| Smith et al. | Applications of nanotechnology for immunology | |
| JP2025107179A (ja) | 治療に好適なｒｎａ製剤 | |
| CN103476431B (zh) | 包含阳离子脂质的用于带负电荷的药物的载体及其制备方法 | |
| CN103374128B (zh) | 两亲性三嵌段共聚物、聚合物纳米载体制剂及制备方法 | |
| CN103372217B (zh) | 聚合物纳米载体制剂及其制备方法和应用 | |
| JP2014522842A5 (enExample) | ||
| Avila et al. | Gene delivery and immunomodulatory effects of plasmid DNA associated with Branched Amphiphilic Peptide Capsules | |
| CN104288758B (zh) | 聚乙二醇化磷脂为载体的胶束多肽疫苗 | |
| JP2018065821A5 (enExample) | ||
| JP7409594B2 (ja) | 医薬組成物、規定のサイズの脂質ベシクル粒子を使用する調製物のための方法、及びそれらの使用 | |
| CN105980447A (zh) | 二氧化硅囊泡的合成方法及其用途 | |
| Mody et al. | Freeze-drying of ovalbumin loaded mesoporous silica nanoparticle vaccine formulation increases antigen stability under ambient conditions | |
| Marin et al. | Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccine | |
| Palumbo et al. | Bacterial invasin: structure, function, and implication for targeted oral gene delivery | |
| WO2023000403A1 (zh) | 一种新型冠状病毒亚蛋白纳米疫苗及其制备方法和应用 | |
| Carmona-Ribeiro | Cationic nanostructures for vaccines | |
| Kabarkouhi et al. | Liposome, nanoliposome and allied technologies in COVID-19 vaccines: key roles and functionalities | |
| CN118576717A (zh) | 生物分子递送载体及其制备和应用 | |
| JPWO2022244825A5 (enExample) |